Barts Health staff searching for volunteers to take part in coronavirus vaccine trial
- Credit: PA
Hospital staff will help to run a Covid-19 vaccine trial based in east London.
Barts Health NHS Trust and Queen Mary University of London are calling for around 400 Londoners to take part at the trust’s vaccines trials centre, based in Bethnal Green Library.
The study, led by Professor Patrick Kennedy, will involve two doses of a vaccine created by The Janssen Pharmaceutical Companies of Johnson & Johnson.
Recruitment will end in March 2021 and the study will last for a year. Residents from all ethnicities, minorities and health groups are asked to take part.
Prof Kennedy said there were still “significant challenges” to overcome “before we have a number of safe and effective vaccines which are available globally”.
You may also want to watch:
He said: “More vaccine trials are needed to better understand how effective they will be in different age groups, in people with chronic medical conditions and for how long the vaccines will provide immunity.
“I am delighted to be the principal investigator on this study and to be working with an outstanding team at Barts Health so we can address these important questions and contribute to the development of a safe and effective vaccine.”
- 1 Police appeal for help after woman raped in Beckton
- 2 Footage shows crowd piling onto train at Canning Town station
- 3 Forest Gate man, 21, charged with dangerous and drug driving
- 4 Newham's Covid-19 case rate 'huge' but there is 'light at end of the tunnel'
- 5 NHS Nightingale London opens to patients without Covid-19
- 6 Double murder accused remanded in custody over ‘brutal’ stabbings
- 7 Volunteers out to bust Covid jab myths and false conspiracy theories
- 8 Dangerous driver arrested after police find drugs and £28k cash
- 9 NHS 'concerned' about Covid vaccine uptake in Newham
- 10 Double murder charge over stabbings, as police name victims
Dr Vanessa Apea, a consultant in sexual health and HIV at Barts Health, added that she recognises the topic of vaccines “divides community”.
She said: “For many, and in particular, black, Asian and ethnic minority communities, the word vaccine generates a lot of fear, rooted in mistrust, which can understandably lead to reluctance in taking part in a trial.
“We know that these communities are disproportionately affected by Covid-19 and this makes it even more important that any outcomes from research, including new treatments and ways to prevent the disease, work for all communities.
“Only by doing this can we truly take control of Covid-19, so we really need people from black, Asian and ethnic minority communities to sign up to learn more and be part of research.”
In total, 30,000 people will receive the trial vaccine worldwide, including 6,000 from the UK.
Staff from all five of the trust’s hospitals will work with researchers, medical school students and volunteers to administer the doses.
To learn more about how to take part, email firstname.lastname@example.org